Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeSalary from: £70,000Department: AssuranceOffice: London Company DescriptionGenomics England partners with the NHS to provide whole genome
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines,
Full-timeSalary from: £70,000Department: AssuranceOffice: London Company DescriptionGenomics England partners with the NHS to provide whole genome
Full-timeSalary from: £74,000Department: ProcurementOffice: London Company DescriptionGenomics England partners with the NHS to provide whole genome
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class
Full-timeSalary from: £74,000Department: ProcurementOffice: London Company DescriptionGenomics England partners with the NHS to provide whole genome
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class
Part-timeSalary from: £7883Department: N/AOffice: London Company DescriptionGenomics England partners with the NHS to provide whole genome sequencing
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class
Full-timeContract type: Permanent Company DescriptionBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class